Governing innovation in the biomedicine knowledge economy: stem cell science in the USA

Brian Salter () and Charlotte Salter

Science and Public Policy, 2010, vol. 37, issue 2, 87-100

Abstract: The burgeoning opportunities of the knowledge economy of biomedicine are matched by the governance challenges it poses to states in the pursuit of national advantage. The future markets are uncertain, the process of knowledge production from basic science to therapeutic product complex, and the possibility of failure ever present. Drawing on theories of the state, innovation and governance, this article explores the governance demands of knowledge production in biomedicine and the roles of state, regional levels of governance and private governance in the policy response. Applying the analytical framework derived from this discussion to the US case, the multi-dimensional governance of stem cell science in the arenas of science, society and the market is examined in an exploration of the USA's innovation capacity in this field. Copyright , Beech Tree Publishing.

Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.3152/030234210X489617 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:37:y:2010:i:2:p:87-100

Access Statistics for this article

Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas

More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().